新闻

Dr. Reddy’s wins CPHI & PMEC India Award for developing a continuous API manufacturing process.

Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) has won the CPHI & PMEC India Award in the category R&D Excellence. The recognition highlights Dr. Reddy’s pioneering work developing a continuous API manufacturing process. This includes the successful implementation of flow chemistry and the end-to- end continuous manufacturing of a drug substance at a commercial scale of approximately 300 kg API/day. This innovative process is significantly faster than the traditional batch-to-batch method, with three chemical conversions now happening in less than two minutes, compared to hours in the batch process.

Commenting on the recognition, Deepak Sapra, Head of API and Services, said, “At Dr. Reddy’s, our focus is on accelerating access, advancing cutting-edge science, and promoting sustainability. Transitioning from batch-to-batch API manufacturing to continuous manufacturing provides significant benefits. It enables us to scale production to meet patient demand while reducing our environmental impact through a greener approach. This award is a testament to the dedication of our R&D team and highlights our commitment to investing in science and technology, nurturing talented scientists, and fostering innovation in product development.”